FMR LLC 13D and 13G filings for Prime Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-05 11:44 am Sale | 2025-09-30 | 13G | PRIME MEDICINE INC PRME | FMR LLC | 6,731,796 3.800% | -994,853 (-12.88%) | Filing |
| 2024-11-12 10:34 am Sale | 2024-11-08 | 13G | PRIME MEDICINE INC PRME | FMR LLC | 7,726,649 6.437% | -1,361,501 (-14.98%) | Filing |
| 2024-02-09 09:49 am Purchase | 2024-02-08 | 13G | PRIME MEDICINE INC PRME | FMR LLC | 9,088,150 9.338% | 625,104 (+7.39%) | Filing |
| 2023-02-09 08:14 am Purchase | 2023-02-09 | 13G | PRIME MEDICINE INC PRME | FMR LLC | 8,463,046 8.706% | 100 (+0.00%) | Filing |
| 2022-10-26 10:20 am Purchase | 2022-10-26 | 13G | PRIME MEDICINE INC PRME | FMR LLC | 8,462,946 8.840% | 8,462,946 (New Position) | Filing |